The launch of a StealthStation technology by Medtronic plc. Ordinary Shares (NYSE:MDT) has finally been accomplished. It took place at the American Academy of Neurological Surgeons (AANS) annual conference in Los Angeles. Given that the company is among the world`s largest providers of medical technology and solutions, the launch was significant. Besides, the technology has been in more than 2.25 million procedures for the last 25 years.
The StealthStation™ S8 model comes at a time when the need for enhanced innovation is beckoning at the wake of every dawn. It will perhaps be a solution to millions of neurosurgeons who prefer to use the newest version of the technology in their procedures. It will not only enhance workflow but it will also facilitate efficiency and the integration of more inclusive data.
Proper surgical guidance standard part of neurosurgery practices
Today’s world is calling for the use of improved technology and software. Colin Buchanan, a neurosurgeon from The Medical Center of Aurora in Colorado uses the StealthStation technology frequently says, “The StealthStation helps me ensure complete resections as well as helps me minimize approach-related complications.”
The transformation of different conditions by the Stealth system
The use of Neuro-navigation technique is becoming more common, and the StealthStation S8 technology has a lot to admire. The senior VP and president of Medtronic`s Brain Therapies division, Brett Wall outlines that they expect the next generation of Stealth system to help in attending to the likes of brain and spine disorders.
It is also worth noting Medtronic`s continued commitment in helping surgeons make critical decisions regarding the procedures they ought to carry out. They will encounter a new and better software interface on the StealthStation S8 technology, which complements their surgical workflows. For example, improved patient registration will promote flexibility and in return quantitative feedback.
Medtronic’s stock closed at $80.65 witnessing an increase of $0.17 or 0.21%.